Skip to content
Scholars Central
Home
Journals
Conferences
Browse conferences
Upcoming conferences
Conferences by city
Calls and deadlines
Proceedings archive
Submit your conference
Subjects
Guidelines and policies
Conference guidelines
For speakers
Sponsor guidelines
Exhibitor guidelines
Abstract submission guidelines
Journal and publication policies
Instructions to authors
Author services
Editorial policies
Publication ethics
About us
Contact
Search
Submit
Search
Home
Journals
Conferences
Browse conferences
Upcoming conferences
Conferences by city
Calls and deadlines
Proceedings archive
Submit your conference
Subjects
Guidelines and policies
Conference guidelines
For speakers
Sponsor guidelines
Exhibitor guidelines
Abstract submission guidelines
Journal and publication policies
Instructions to authors
Author services
Editorial policies
Publication ethics
About us
Contact
My list
Submit a manuscript
Articles
/
Supplemental Table 1: The original questionnaire…
Article
Supplemental Table 1: The original questionnaire comparing the FSC pMDI (Aroair®) and FFC pMDI (Flutiform®) treatment. FSC: Fluticasone propionate/Salmeterol Combination; FFC: Fluticasone propionate/Formeterol Combination; pMDI, pressurized Metered Dose Inhaler.
Full text (PDF)
Save
Cite
Add to collection
Share
Report
a problem with this article